Literature DB >> 28497397

Xuebijing Injection () and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury.

Shu-Kun Zhang1, Yu-Zhen Zhuo1, Cai-Xia Li1, Lei Yang1, Hong-Wei Gao2, Xi-Mo Wang3.   

Abstract

OBJECTIVE: To investigate the effect of combined application of Xuebijing Injection ( , XBJ) and resolvin D1 (RvD1) on survival rate and the underlying mechanisms in mice with sepsisinduced lung injury.
METHODS: The cecal ligation and puncture (CLP) method was used to develop a mouse sepsis model. Specific pathogen free male C57BL/6 mice were randomly divided into 5 groups (n=20 each): sham, CLP, CLP+XBJ, CLP+RvD1 and CLP+XBJ+RvD1. After surgery, mice in the CLP+XBJ, CLP+RvD1 and CLP+XBJ+RvD1 groups were given XBJ (25 μL/g body weight), RvD1 (10 ng/g body weight), and their combination (the same dose of XBJ and RvD1), respectively. In each group, 12 mice were used to observe 1-week survival rate, while the rest were executed at 12 h. Whole blood was collected for flow cytometric analysis of leukocyte adhesion molecules CD18, lung tissues were harvested for observing pathological changes, and testing the activity of myeloperoxidase (MPO) and the expression of intercellular cell adhesion molecule 1 (ICAM-1).
RESULTS: Compared with the CLP group, the histopathological damage of the lung tissues was mitigated, MPO activity was decreased in the CLP+XBJ and CLP+RvD1 groups (P<0.05). In addition, the 1-week survival rate was improved, proportion of CD18-expressing cells in whole blood and ICAM-1 protein expression in lung tissue were decreased in the CLP+XBJ+RvD1 group (P<0.05 or P<0.01).
CONCLUSIONS: XBJ together with RvD1 could effectively inhibit leukocyte adhesion, reduce lung injury, and improve the survival rate of mice with sepsis.

Entities:  

Keywords:  Chinese medicine; Xuebijing Injection; lung injury; resolvin D1; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28497397     DOI: 10.1007/s11655-017-2959-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  20 in total

Review 1.  Cytokine-mediated inflammation in acute lung injury.

Authors:  Richard B Goodman; Jérôme Pugin; Janet S Lee; Michael A Matthay
Journal:  Cytokine Growth Factor Rev       Date:  2003-12       Impact factor: 7.638

2.  [A prospective multicenter clinical study of Xuebijing injection in the treatment of sepsis and multiple organ dysfunction syndrome].

Authors:  Jie Gao; Lingbo Kong; Si Liu; Zhiqiao Feng; Hong Shen; Qingquan Liu
Journal:  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue       Date:  2015-06

Review 3.  Endothelial-leukocyte adhesion molecules in human disease.

Authors:  M P Bevilacqua; R M Nelson; G Mannori; O Cecconi
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

4.  Time-dependent reversal of sepsis-induced PMN uptake and lung vascular injury by expression of CD18 antagonist.

Authors:  Ning Xu; Xiao-Pei Gao; Richard D Minshall; Arshad Rahman; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

5.  Therapeutic hypercapnia enhances the inflammatory response to endotoxin in the lung of spontaneously breathing rats.

Authors:  Faraz M Norozian; Michael Leoncio; Dan Torbati; Keith Meyer; Andre Raszynski; Balagangadhar R Totapally
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

Review 6.  Cellular and molecular mechanisms regulating silica-induced adhesion molecule expression in mice.

Authors:  A K Hubbard; M Thibodeau; C Giardina
Journal:  J Environ Pathol Toxicol Oncol       Date:  2001       Impact factor: 3.567

7.  Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice.

Authors:  X Gao; N Xu; M Sekosan; D Mehta; S Y Ma; A Rahman; A B Malik
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

9.  Quantitation of ICAM-1 expression in mouse lung during pneumonia.

Authors:  A R Burns; F Takei; C M Doerschuk
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

10.  Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice.

Authors:  Qiao Wang; Xin Wu; Xiaowen Tong; Zhiling Zhang; Bing Xu; Wugang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

View more
  3 in total

1.  Efficacy of Xuebijing Injection () on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial.

Authors:  Wei Gao; Na Li; Xiao-Guang Cui
Journal:  Chin J Integr Med       Date:  2018-07-31       Impact factor: 1.978

2.  ResolvinD1 attenuates high-mobility group box 1-induced epithelial-to-mesenchymal transition in nasopharyngeal carcinoma cells.

Authors:  Pingli Yang; Shan Chen; Gang Zhong; Yan Wang; Weijia Kong; Yanjun Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-01

3.  DDAH1 Promotes Lung Endothelial Barrier Repair by Decreasing Leukocyte Transendothelial Migration and Oxidative Stress in Explosion-Induced Lung Injury.

Authors:  Peifang Cong; Changci Tong; Shun Mao; Lin Shi; Xiuyun Shi; Ying Liu; Hongxu Jin; Yunen Liu; Mingxiao Hou
Journal:  Oxid Med Cell Longev       Date:  2022-05-17       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.